# Study Evaluating InductOs in Diaphyseal Tibia Fractures

> **NCT00161616** · PHASE4 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 277 (actual)

## Conditions studied

- Tibial Fractures

## Interventions

- **DRUG:** InductOs

## Key facts

- **NCT ID:** NCT00161616
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 277 (ACTUAL)
- **Last updated:** 2009-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161616, "Study Evaluating InductOs in Diaphyseal Tibia Fractures". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00161616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*